tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BrainsWay Secures $20M Financing and Reports Strong Q2 2025 Growth

Story Highlights
BrainsWay Secures $20M Financing and Reports Strong Q2 2025 Growth

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from Brainsway ( (BWAY) ) is now available.

On August 13, 2025, BrainsWay announced a strategic partnership with Valor Equity Partners, securing $20 million in equity financing to strengthen its position in the TMS industry. The company reported strong financial performance in Q2 2025, with revenue of $12.6 million, a 26% increase year-over-year, and a net profit of $2 million, up 240% year-over-year. BrainsWay also raised its full-year 2025 revenue and EBITDA guidance, highlighting its transition to a recurring revenue model and its strategic initiatives to accelerate growth, including a $5 million minority investment in Stella, a leading U.S.-based interventional psychiatry platform.

The most recent analyst rating on (BWAY) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Brainsway stock, see the BWAY Stock Forecast page.

Spark’s Take on BWAY Stock

According to Spark, TipRanks’ AI Analyst, BWAY is a Outperform.

Brainsway’s strong financial performance and positive earnings call guidance significantly contribute to its overall score. While the technical indicators show moderate bullish momentum, the high P/E ratio and absence of a dividend yield are valuation concerns.

To see Spark’s full report on BWAY stock, click here.

More about Brainsway

BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The company is the first and only TMS company to obtain four FDA-cleared indications, including major depressive disorder (MDD), obsessive-compulsive disorder (OCD), anxious depression, and smoking addiction. BrainsWay has a strong presence in key markets such as the U.S., Canada, Asia, India, and Europe, and operates on a recurring revenue model through rentals and pay-per-use agreements.

Average Trading Volume: 46,225

Technical Sentiment Signal: Buy

Current Market Cap: $230.6M

See more data about BWAY stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1